SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

ATRY (ATRY) News

Follow ATRY (ATRY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ATRY Asset market Sector Markets 90 days 4 Updated Sep 10, 2026, 02:13 PM UTC Open live news feed
L ATRY revenue up 9.4% in 1H 2026 as EBITDA rises 21.3% ATRY reported revenue up 9.4% year-over-year in 1H 2026. The company said EBITDA rose 21.3% and net debt fell 79.2% after divesting its Prevention Division. EARNINGS | Sep 10, 2026, 02:13 PM UTC L Atrys reports H1 2026 revenue up 9.4% and EBITDA up 21.3% Atrys Health reported H1 2026 revenue of €77.7M, up 9.4%, with EBITDA up 21.3%. The company said net debt fell 79.2% after the ASPY sale and that full-year guidance was reaffirmed. EARNINGS | Sep 10, 2026, 07:48 AM UTC L ATRY reports 1H 2026 revenue growth and EBITDA rise YoY Atrys Health SA said 1H 2026 revenue grew YoY to €77.7M and EBITDA rose YoY. Net debt fell 79.2% after the Prevention segment sale; 2026 guidance was reaffirmed. EARNINGS | Sep 10, 2026, 06:39 AM UTC L Atrys H1 Net Loss At €6.4 Mln Atrys Health SA BME:ATRY:Source text EQUITY | Sep 10, 2026, 06:28 AM UTC